Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Neoadjuvant chemotherapy is associated with altered immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research Dias Costa, A., Vayrynen, S. A., Chawla, A., Zhang, J., Vayrynen, J. P., Lau, M. C., Williams, H. L., Yuan, C., Morales-Oyarvide, V., Elganainy, D., Singh, H., Cleary, J. M., Perez, K., Ng, K., Freed-Pastor, W., Mancias, J. D., Dougan, S. K., Wang, J., Rubinson, D. A., Dunne, R. F., Kozak, M. M., Brais, L., Reilly, E., Clancy, T., Linehan, D. C., Chang, D. T., Hezel, A. F., Koong, A. C., Aguirre, A., Wolpin, B. M., Nowak, J. A. 2022

Abstract

PURPOSE: Neoadjuvant chemotherapy is increasingly administered to patients with resectable or borderline resectable pancreatic ductal adenocarcinoma (PDAC), yet its impact on the tumor immune microenvironment is incompletely understood.EXPERIMENTAL DESIGN: We employed quantitative, spatially-resolved multiplex immunofluorescence and digital image analysis to identify T-cell subpopulations, macrophage polarization states and myeloid cell subpopulations in a multi-institution cohort of up-front resected primary tumors (n=299) and in a comparative set of resected tumors after FOLFIRINOX-based neoadjuvant therapy (n=36) or up-front surgery (n=30). Multivariable-adjusted Cox proportional hazards models were used to evaluate associations between the immune microenvironment and patient outcomes.RESULTS: In the multi-institutional resection cohort, immune cells exhibited substantial heterogeneity across patient tumors and were located predominantly in stromal regions. Unsupervised clustering using immune cell densities identified four main patterns of immune cell infiltration. One pattern, seen in 20% of tumors and characterized by abundant T cells (T cell-rich) and a paucity of immunosuppressive granulocytes and macrophages, was associated with improved patient survival. Neoadjuvant chemotherapy was associated with a higher CD8:CD4 ratio, greater M1:M2-polarized macrophage ratio, and reduced CD15+ARG1+ immunosuppressive granulocyte density. Within neoadjuvant-treated tumors, 64% showed a T-cell-rich pattern with low immunosuppressive granulocytes and macrophages. M1-polarized macrophages were located closer to tumor cells after neoadjuvant chemotherapy and colocalization of M1-polarized macrophages and tumor cells was associated with greater tumor pathologic response and improved patient survival.CONCLUSION: Neoadjuvant chemotherapy with FOLFIRINOX shifts the PDAC immune microenvironment towards an anti-tumorigenic state associated with improved patient survival.

View details for DOI 10.1158/1078-0432.CCR-22-1125

View details for PubMedID 36129461